Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing

Based on separate protective mechanisms related to lipid metabolism, viral cell entry and inflammation, fibrate treatment might be advantageous among patients who have been taking fibrates before SARS-CoV-2 infection and continue taking them during the infection. Based on published data on hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuorio, Alpo, Brinck, Jonas, Kovanen, Petri T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278418/
https://www.ncbi.nlm.nih.gov/pubmed/35818956
http://dx.doi.org/10.1080/07853890.2022.2095667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278418/
https://www.ncbi.nlm.nih.gov/pubmed/35818956
http://dx.doi.org/10.1080/07853890.2022.2095667

Ejemplares similares